Clinical Trials and Post-Market Side Effects
Listen now
Description
Drs. Sarah Read, M. Ali Khan, and Ajay Kuriyan join a group discussion on incorporating newly approved medications into practice, focusing on real-world examples of Vuity (pilocarpine drops), brolucizumab, and drugs for dry AMD in trial. For all episodes or to claim CME credit for selected episodes, visitĀ www.aao.org/podcasts.
More Episodes
Published 03/21/24
Drs. Rupa Wong and Dagny Zhu join host Amanda Redfern to share their experience and expertise using social media to successfully promote their ophthalmic practices and enhance their professional careers. For all episodes or to claim CME credit for selected episodes, visitĀ www.aao.org/podcasts.
Published 03/21/24
Drs. Meghan Berkenstock, Stella Kim, and Lauren Dalvin join the show again to teach us about immune checkpoint inhibitors: game changers in oncology, but with a host of ocular side effects. All eye providers will be seeing more patients on this class of medication, and our panel teaches us what...
Published 03/08/24